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Smad7 mediates transforming growth factor-–induced apo- In glomerular disease, mesangial cell proliferation is
ptosis in mesangial cells. an important pathology that can potentially progress to
Background. In addition to inhibiting cell growth, trans- sclerosis and end-stage renal disease [1, 2]. Glomerularforming growth factor- (TGF-) has recently been reported
mesangial cells are thought to play a key role in promot-to induce apoptosis in various cell lines. Smad proteins are the
ing glomerular scarring.downstream effectors of TGF- signaling. Among them, Smad7
exerts negative feedback control over the action of TGF-. Apoptosis is very important for homeostasis in the
However, we do not know how the Smad proteins contribute formation of various diseases. Mesangial cells have also
to TGF-–induced apoptosis in mesangial cells. To investigate been observed to undergo apoptosis in various glomeru-the function of Smad proteins, we examined the effect of Smad
lar diseases [3], and recent experimental evidence sug-overexpression using adenoviral vector in mesangial cells.
gests that this apoptosis of mesangial cells mediates theMethods. Primary cultured rat mesangial cells were trans-
fected with Smad7-promoter-luciferase-plasmid by electropora- resolution of glomerular hypercellular injury and plays
tion. Smad7 promoter activity was investigated by luciferase assay. a critical role in the regulation of cellularity following
The apoptotic phenomena elicited by TGF- and Smad7 over-
renal injury [4, 5]. Apoptotic phenomena were observedexpression were investigated using adenoviral vector (AdCMV-
not only in experimental glomerulonephritis, but also inSmad7). Apoptosis was detected by the cell death detection
ELISA assay, CPP32/caspase-3 assay, and nucleosomal DNA human glomerular diseases such as IgA nephropathy and
laddering. lupus nephritis [6]. The authors of these studies sug-
Results. TGF- significantly increased the protein expres- gested that apoptosis was at least partially involved in the
sion and the promoter activity of Smad7 in rat mesangial cells.
cell deletion of various progressive glomerular diseases.Overexpression of Smad7 induced DNA fragmentation and
Transforming growth factor- (TGF-) affects manysignificant increases in cell death ELISA and CPP32/caspase-3
assay. On the other hand, overexpression of Smad2 and Smad3 functions in many different types of cells [7, 8]. TGF-
did not elicit any significant increases in CPP32/caspase-3 activ- exerts manifold effects on mesangial proliferation, pro-
ity. Furthermore, the antisense oligonucleotide to Smad7 pre- moting it at lower concentrations and suppressing it atvented the TGF-–induced apoptosis. Overexpression of Smad7
higher concentrations [9]. In a model of antithymocytedid not affect nuclear factor-B activity in mesangial cells.
serum-induced acute mesangial proliferative glomerulo-Conclusions. These data indicate that TGF-–induced apo-
ptosis in mesangial cells is mediated through the activation of nephritis, TGF- production promoted the accumulation
caspase-3 by Smad7, but not by Smad2 or Smad3. Our results of glomerular extracellular matrix [10]. Likewise, in a
provide new clarification on the function of Smad7 in TGF- model of anti-glomerular basement membrane antigen-signaling in mesangial cells.
induced crescentic glomerulonephritis, antiserum against
TGF- suppressed experimental glomerulonephritis [11].
Thus, TGF- is known to be involved in the mesangial
proliferation in various types of nephritis. Separate ex-
periments also have demonstrated that TGF- induces
apoptosis in mesangial cells [12], although there has been
little clarification of the pathway of this TGF-–inducedKey words: cell death, TGF-, signal transduction, caspase, nuclear
factor-kappa B, adenoviral vector, sclerosis, glomerulus. apoptosis.
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analysis of Smad protein expression is expected to pro- experiments after 5 to 10 passages. The cells were incu-
bated in medium plus 20% fetal calf serum (FCS) untilvide key information on the pathway of TGF-–induced
apoptosis in mesangial cells. While several recent articles reaching approximately 80% confluence, then either
transfected with adenovirus for 48 hours, or exposed tohave reported that Smad7 regulates apoptosis, the over-
all effect of this protein on apoptosis remains controver- TGF- (1 ng/mL) or tumor necrosis factor- (TNF-;
10 ng/mL) for 24 hours in medium containing 0.5% FCS.sial. Smad7 inhibited TGF-–induced apoptosis in B cells
[14], M1 cells, and Hep3B cells [15], whereas it was found
Caspase-3 assaysto mediate TGF-–induced apoptosis in prostatic carci-
noma cells [16], Mv1Lu cells, Madin-Darby canine kid- A Caspase-3 Fluorometric Protease Assay Kit (MBL,
Tokyo, Japan) was used for measurement of caspase-3ney (MDCK) cells [17], and podocytes [18]. Moreover,
a recent report showed that TGF- and Smad7 induced activities as previously described [24]. In brief, the cells
were plated in six-well dishes, cultured in medium, col-apoptosis in podocytes through different downstream
pathways, providing a novel molecular mechanism for lected, and lysed in lysis buffer at indicated times. After
the protein concentration was normalized by the Brad-podocyte depletion in progressive glomerulosclerosis [18].
While the apoptosis in endocapillary/mesangial cells was ford assay, the lysates were incubated with the same
amounts of reaction buffer and 50 mmol/L DEVD-AFCshown to be significantly increased at the advanced stage
of glomerulosclerosis in TGF- transgenic mice, the re- substrate for two hours at 37C. Fluorescence was moni-
tored with an excitation wavelength of 400 nm and anport did not go into detail on how Smad7 and TGF-
contribute to apoptosis in mesangial cells. emission wavelength of 505 nm.
Studies on various cell-lines have confirmed that TGF-
Cell death ELISAand receptor-activated Smads (R-Smads) such as Smad3
stimulate inhibitory Smads (I-Smads), and also that the Histone-associated DNA fragments were quantitated
by enzyme-linked immunosorbent assay (ELISA; Boe-Smad signaling system exerts an auto-regulatory action
via a negative feedback loop [19–21]. However, there rhinger, Mannheim, Germany). All cells from each well
were collected by trypsinization and pipetting, pelletedhas been no clear data on primary mesangial cells.
By examining the effect of Smad7 overexpression us- (800 rpm, 5 min), lysed, and subjected to the capture
ELISA according to the manufacturer’s protocol. Cyto-ing adenovial vector in cultured primary rat mesangial
cells, we determined that Smad7 overexpression induced solic proteins were collected using cell lysis buffer accord-
ing to the manufacturer’s protocol. After a 30-minuteapoptosis, and that the TGF-–induced apoptosis was
mediated by Smad7 rather than Smad2 or Smad3. incubation of the cells with cell lysis buffer, the samples
were centrifuged for 10 minutes (15,000 rpm), the nuclei
were formed into pellets, the cytoplasmic fraction be-
METHODS
came supernatant, and the supernatants were collected
Recombinant adenoviruses for the ELISA assay. Each experiment was carried out in
triplicate and repeated independently at least five times.The recombinant adenovirus expressing the LacZ gene
(AdCMV-LacZ) and the replication-defective, recombi-
Ladder assaysnant adenoviruses expressing the Smad7 gene (AdCMV-
Smad7) were prepared as described previously [22–24]. Adherent and floating cells were collected and lysed
in a medium containing 10 mmol/L Tris (pH 8.0), 100Recombinant adenoviruses expressing the Smad2 gene
(AdCMV-Smad2) and Smad3 gene (AdCMV-Smad3) mmol/L NaCl, and 25 mmol/L ethylenediaminetetraace-
tic acid (EDTA), 0.5% sodium dodecyl sulfate (SDS),were kindly provided by Dr. K. Miyazono. Each adenovi-
rus preparation was titrated by plaque-assay on 293 cells. and 1.0 mg/mL proteinase K at 37C for four hours.
DNA was extracted from the digested cells as previouslyViral stocks [5  108 plaque-forming units (pfu)/mL]
were stored at 80C and thawed on ice just before use. described [26], divided into 30g portions, and subjected
to electrophoresis on 1.5% agarose gels.The efficiency of adenovirus-mediated gene transfer is
over 90% in mesangial cells [23].
Antisense oligonucleotide
Cell culture and preparation of extracts Antisense and scrambled random sequence oligonu-
cleotides (oligonucleotide phosphorothioates) againstMesangial cell strains from male Sprague-Dawley
(SD) rats were isolated and characterized as previously Smad7 were synthesized by a DNA synthesizer (Model
8909; Perseptive Biosystems, Cambridge, MA, USA) asreported [25]. Cells were maintained in RPMI 1640 me-
dium supplemented with 20% fetal bovine serum, 100 previously described [16, 27]. The Smad7 antisense oli-
gonucleotide was designed around the region 107-127U/mL penicillin, 100 g/mL streptomycin, 5 g/mL of
insulin, 5 g/mL of transferrin, and 5 ng/mL selenite at (5-GTCGCCCCTTCTCCCCGCAGG-3) of the rat
Smad7 complementary DNA sequence (GenBank acces-37C in a 5% CO2 incubator. The cells were used in the
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sion number AF159626). The Smad7 sense oligonucleo- ratio with 5 Laemmli buffer and heated for four min-
utes at 94C. Twenty micrograms of protein was resolvedtide was 5-CCTGCGGGGAGAAGGGGCGAC-3. Rat
mesangial cells were exposed to TGF- treatment (1 in sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE), transferred to an Immobilonng/mL) or TGF- treatment with antisense oligonucleo-
tide to Smad7 (AS) or TGF- treatment with sense oligo- P membrane (Daiichikagaku, Tokyo, Japan), and then
probed with the following antibodies: goat polyclonalnucleotide to Smad7 (sense) for 24 hours.
antibodies against Smad7, Smad2, and Smad3 (Santa
Transient transfection and luciferase assay Cruz Biotechnology, Santa Cruz, CA, USA), or a rabbit
polyclonal antibody against actin (Santa Cruz Biotech-Rat mesangial cells were transfected by the electropor-
ation method. The Smad7-promoter luciferase construct nology) or with rabbit polyclonal antibodies against Ser473-
phospho-specific Akt, total-Akt, Ser32-phospho-specificwas kindly provided by Dr. Y. Chen [21]. Data are repre-
sentative of at least four independent experiments per- IB-, and total IB- (Cell Signaling Technology, Inc.,
Beverly, MA, USA) . The experiments for the detectionformed in duplicate, and expressed as the N-fold increase
in luciferase activity calculated relative to the indicated of Smad7, Smad2, and Smad3 used the primary antibod-
ies (diluted 1/1000) and horseradish peroxidase (HRP)-level of Smad7 promoter activity. Plasmid DNAs (10
g) were transfected by the electroporation method. For conjugated anti-goat IgG (diluted 1/2500) as a secondary
antibody. The blots for the detection of Ser473-phospho-experiments performed in exponentially growing cells,
the Smad7-promoter luciferase activity was measured 48 specific Akt, total-Akt, Ser32-phospho-specific IB-,
total IB-, and actin used the primary antibodies (di-hours after transfection.
The plasmids were nuclear factor-kappa B (NF-B)- luted 1/1000) and HRP-conjugated anti-rabbit IgG (di-
luted 1/2500) as a secondary antibody. The bands wereluciferase-plasmids (NF-B elements  5 and luciferase
fusion plasmid) as the NF-B–sensitive promoter from visualized using the enhanced chemiluminescence (ECL)
system (Amersham, Little Chalfort, UK) after extensiveStratagene (La Jolla, CA, USA). Data are representative
of at least four independent experiments performed in washing of the membranes. ECL films were scanned
using an Epson scanner (Nagano, Japan).duplicate, and expressed as the N-fold increase in lucifer-
ase activity calculated relative to the indicated level of Controls for protein loading were identified by actin
as the internal standard [31, 32].NF-B–sensitive promoter activity. Plasmid DNAs (10
g) were transfected by the electroporation method. In
Electrophoretic mobility shift assay (EMSA)the experiments performed with exponentially growing
cells, the cells after the NF-B plasmids were transfected, Nuclear extract from mesangial cells was prepared
as described previously, with minor modifications [27].incubated in 20% FCS-containing medium for 24 hours,
and then either infected with adenovirus for 48 hours in Firstly, mesangial cells were collected using trypsin and
centrifuged. After resuspending the cell pellets in tubesmedium containing 0.5% FCS, or incubated for 24 hours
and exposed to TNF- treatment (10 ng/mL) for 24 hours containing 400 L of ice-cold buffer A (10 mmol/L
HEPES, pH 7.9, 10 mmol/L KCl, 0.1 mmol/L EDTA,in medium containing 0.5% FCS. The NF-B–sensitive
promoter luciferase activity was measured 48 hours after 0.1 mmol/L EGTA, 1 mmol/L DTT, 0.5 mmol/L PMSF),
25 L of a 10% Nonidet P-40 solution was added, andinfection. Normalization was achieved by cotransfecting
3.0 g of pCH110, a -galactosidase reporter construct, the tubes were vigorously shaken for 30 seconds on an
orbital shaker and centrifuged for 30 seconds in a micro-as an internal control for the transfection efficiency. Lu-
ciferase and -galactosidase activities were measured ac- centrifuge. Next, the nuclear pellets were resuspended in
tubes containing 100 L of ice-cold buffer C (20 mmol/Lcording to the manufacturer’s instructions (Promega,
Madison, WI, USA) protocol. Transfection efficiency of HEPES, pH 7.9, 400 mmol/L NaCl, 1 mmol/L EDTA, 1
mmol/L EGTA, 1 mmol/L DTT, 1 mmol/L PMSF, 1g/mLelectroporation is around 20% in mesangial cells [28].
aprotinine, and 1 g/mL pepstatin A), vigorously rocked
Western blot analysis at 4C for 15 minutes on a shaking platform, and centri-
fuged for 10 minutes at 4C. The collected supernatantsThe proteins were extracted from mesangial cells us-
ing an extraction buffer containing 20 mmol/L HEPES, were tested by a gel shift assay system according to the
manufacturer’s protocol (Promega). Briefly, nuclear ex-pH 7.5, 250 mmol/L KCl, 0.1 mmol/L EDTA, 0.1 mmol/L
egtazic acid (EGTA), 10% glycerol, 0.1% (vol/vol) Noni- tracts (10g of each) underwent a reaction in a premixed
incubation buffer (included in the kit) with 	-32P-enddet P-40, 0.5 mmol/L dithiothreitol (DTT), 0.5 mmol/L
phenylmethylsulfonyl fluoride (PMSF), 1 g/mL aproti- labeled nuclear factor-B (NF-B) consensus oligonu-
cleotides (5-AGTTGAGGGGACTTTCCCAGGC-3)nine, and 1 g/mL pepstatin A, as described previously
[28–30]. Lysates were allowed to remain on ice for 30 for 30 minutes at 25C. To establish the specificity of the
reaction, competition assays were performed with 100-minutes, and then centrifuged at 15,000 rpm for 30
minutes at 4C. The soluble lysates were mixed at a 1:4 fold excess of unlabeled NF-B consensus, or unrelated
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Fig. 1. Effect of transforming growth factor- (TGF-) on Smad7 in
rat mesangial cells. (A) Western blot analysis of Smad7 on cell lysates
from rat mesangial cells stimulated with TGF-. Rat mesangial cells
were treated with or without TGF- (1 ng/mL) for 24 hours. The protein
expression of Smad7 was determined by Western blot analysis using
20g of cell lysate protein and a specific antibody. (B) Smad7-promoter-
luciferase activity. Rat mesangial cells were transiently co-transfected Fig. 2. Adenovirus-mediated Smad7 gene transfer (AdCMV-Smad7)
with Smad7-promoter-luciferase plasmid and -galactosidase plasmid, induced nucleosomal laddering of DNA in rat mesangial cells. (A)
and then treated with or without TGF- (1 ng/mL) for 24 hours. Lucifer- Western blot analysis of Smad7 on cell lysates from mesangial cells.
ase specific activity was determined by luciferase assay. The luciferase Rat mesangial cells were either transfected with AdCMV-Smad7 or
activity was normalized by -galactosidase activity (N 
 6; data are AdCMV-LacZ for 48 hours, or exposed to TGF- treatment (1 ng/mL)
mean  SEM; *P  0.001). for 24 hours. Twenty micrograms of cell lysate protein were used for
Western blot analysis. The protein production of Smad7 was determined
by Western blot analysis using a specific antibody. (B) DNA ladder
assays. Rat mesangial cells were either transfected with AdCMV-Smad7
or AdCMV-LacZ for 48 hours, or exposed to TGF- treatment (1 ng/mL)oligonucleotides (activated protein-1, AP-1; Promega).
for 24 hours. Extracted DNA from adherent and floating cells was
After the reaction, the samples were analyzed on a 6% subjected to electrophoresis on 1.5% agarose gels.
nondenaturing polyacrylamide gel. The gel was dried
and exposed to x-ray film.
Statistics Smad7 overexpression stimulated apoptosis in
mesangial cellsThe results were given as means  SEM. The differ-
ences were tested using two way-analysis of variance Earlier studies have shown variability in the Smad7
followed by the Scheffe’s test for multiple comparisons. regulation of apoptosis in different cell lines [14–18].
Two groups were compared by the unpaired t test. P  To explore whether Smad7 can induce the apoptotic
0.05 was considered significant. phenomena in mesangial cells, Smad7 was overexpressed
using the adenoviral vector. Primary cultured rat mesan-
gial cells were transfected with adenovirus (AdCMV-RESULTS
Smad7 or AdCMV-LacZ as a control) for 48 hours or ex-
TGF- induced Smad7 in mesangial cells posed to TGF- treatment (1 ng/mL) for 24 hours.
Firstly, to determine the mechanism of Smad7 in pri- First, to verify whether an adenoviral system for Smad7
mary cultured rat mesangial cells, the effect of TGF- could achieve efficient expression of the Smad7 protein,
on the protein expression of Smad7 was examined. Rat Smad7 protein expression was determined by Western
mesangial cells were treated with or without TGF- blot analysis using a specific antibody. As shown in Fig-
(1 ng/mL) for 24 hours. The protein expression of Smad7 ure 2A, AdCMV-Smad7 increased the Smad7 expression
was determined by Western blot analysis using 20 g to a significantly greater extent than AdCMV-LacZ at
of cell lysate protein and a specific antibody. TGF- 48 hours post-transfection.
significantly increased the Smad7 expression, as shown In the next experiment, using the agarose gel electro-
in Figure 1A. phoresis of fragmented DNA, nucleosomal DNA lad-
In addition, the promoter activity of Smad7 was mea- dering was found to be induced in the cells treated by
sured to examine the regulation of Smad7 expression by TGF- treatment and adenovirus-mediated Smad7 gene
TGF- in rat mesangial cells. The mesangial cells were transfer, but not in the control cells without adenoviral
transiently transfected with Smad7-promoter-luciferase- treatment and the cells exposed to AdCMV-LacZ (Fig.
plasmid by the electroporation method. 2B). This meant that the apoptosis in rat mesangial cells
Compared with the Smad7 promoter-luciferase activ- was induced not by viral toxicity, but by the overexpres-
ity in the controls, the promoter activity increased about sion of Smad7.
2.1-fold under TGF- treatment (Fig. 1B). Next the apoptotic stimulation was quantified using
These results confirmed that TGF- induced Smad7 the cell death detection ELISA assay and CPP32/cas-
pase-3 fluorometric protease assay. In the cell death de-in primary mesangial cells.
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Fig. 4. Smad7-overexpression-stimulated apoptosis, assessed by CPP32/Fig. 3. Smad7-overexpression-stimulated apoptosis, assessed by cell
caspase-3 fluorometric protease assays. Rat mesangial cells were trans-death detection ELISA assays. Rat mesangial cells were transfected
fected with adenovirus (AdCMV-Smad7 or AdCMV-LacZ) for 48with adenovirus (AdCMV-Smad7 or AdCMV-LacZ) for 48 hours, or
hours, or exposed to TGF- treatment (1 ng/mL) for 24 hours. Cellexposed to TGF- treatment (1 ng/mL) for 24 hours. Cell lysate from
lysate from adherent and floating cells was used for CPP32/caspase-3adherent and floating cells was subjected to cell death ELISA assay
assay (N 
 6; data are mean  SEM; *P  0.001).(N 
 6; data are mean  SEM; *P 
 0.002, **P 
 0.013, ***P 
0.001).
Smad3, AdCMV-Smad7, or AdCMV-LacZ) for 48 hours
tection ELISA assay, AdCMV-Smad7 induced a signifi- or exposed to TGF- treatment (1 ng/mL) for 24 hours.
cant 2.6  0.2-fold increase in activation compared to First, to verify whether an adenoviral system for Smad2
AdCMV-LacZ, and the level of apoptosis induced by and Smad3 could elicit efficient expressions of the Smad
Smad7 overexpression tended to increase with the dose proteins, the protein expressions were determined by
of adenovirus (Fig. 3). The cell death ELISA examina- Western blot analysis using specific antibodies. As shown
tion of mesangial cells exposed to TGF- showed that in Figure 5 A and B, AdCMV-Smad2 and AdCMV-
the apoptotic signals were significantly increased by 2.4 Smad3 increased the expressions of Smad2 and Smad3 re-
0.1-fold over the control level. spectively, to a significantly greater extent than AdCMV-
Similarly, overexpression of Smad7 by adenovirus in- LacZ at 48 hours post-transfection.
duced a significant 2.8  0.1-fold increase over the level Next, the apoptotic phenomenon was quantified using
with AdCMV-LacZ, and TGF- induced a 2.5  0.1- CPP32/caspase-3 fluorometric protease assay. Compared
fold increase in CPP32/caspase-3 activity over the level with the mesangial cells exposed to AdCMV-LacZ infec-
in controls (Fig. 4). The CPP32/caspase-3 activity in- tion, the cells exposed to AdCMV-Smad2 and AdCMV-
duced by Smad7 overexpression also tended to increase Smad3 did not show a significant increase in caspase-3
with higher doses of adenovirus. On the other hand, activity (Fig. 5C). In contrast, overexpression of Smad7
overexpression of LacZ did not show an apoptotic in- stimulated a 3.4  0.1-fold increase over the level in
crease in CPP32/caspase-3 activity (Fig. 4). These results AdCMV-LacZ–exposed cells, and TGF- induced a 2.6
demonstrated that Smad7 overexpression induced apo- 0.1-fold increase in CPP32/caspase-3 activity compared
ptosis in mesangial cells, and that the apoptotic pathways with the control level. These results demonstrated that
initiated by Smad7 and TGF- in mesangial cells were it was not the R-Smads such as Smad2 and Smad3, but
related to the caspase cascades and activation of caspase-3. Smad7 itself that increased apoptosis through the cas-
pase cascade along with TGF-.
Smad2 and Smad3 overexpression did not induce
increased caspase-3 activity in mesangial cells The antisense oligonucleotide to Smad7 forestalled
TGF-–induced apoptosis in mesangial cellsAfter confirming that Smad7 and TGF- induced apo-
ptosis through the activation of caspase-3 in mesangial The activation of caspases is involved in the apoptotic
regulation by both TGF- and Smad7 overexpression.cells, we examined whether R-Smads such as Smad2 and
Smad3 also were able to stimulate apoptosis in mesangial To investigate the relationship between Smad7 and TGF-,
we tried to block Smad7 expression using the antisensecells. Primary cultured rat mesangial cells were either
transfected with adenovirus (AdCMV-Smad2, AdCMV- method, and then confirmed whether Smad7 expression
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Fig. 5. Smad2 and Smad3 overexpression did
not induce significant changes in CPP32/cas-
pase-3 activity. (A) Western blot analysis of
Smad2 on cell lysates from mesangial cells.
Rat mesangial cells were transfected with ei-
ther AdCMV-Smad2 or AdCMV-LacZ for 48
hours. Twenty micrograms of cell lysate pro-
tein were used for Western blot analysis. The
protein production of Smad2 was determined
by Western blot analysis using a specific anti-
body. (B) Western blot analysis of Smad3 on
cell lysates from mesangial cells. Rat mesan-
gial cells was transfected with either AdCMV-
Smad3 or AdCMV-LacZ for 48 hours. Twenty
micrograms of cell lysate protein were used
for Western blot analysis. The protein produc-
tion of Smad3 was determined by Western
blot analysis using a specific antibody. (C ) Rat
mesangial cells were transfected with adeno-
virus (AdCMV-Smad2 or AdCMV-Smad3 or
AdCMV-Smad7 or AdCMV-LacZ) for 48 hours,
or exposed to TGF- treatment (1 ng/mL) for
24 hours. Cell lysate from adherent and floating
cells was used for CPP32/caspase-3 assay (N 

6; data are mean  SEM; *P  0.001).
was essential for TGF-–induced apoptosis. Rat mes-
angial cells were exposed to TGF- treatment alone (1
ng/mL), to TGF- treatment with the synthetic antisense
oligonucleotide to Smad7, or to TGF- treatment with
the sense oligonucleotide to Smad7 for 24 hours.
According to our Western blot analysis, the Smad7
antisense oligonucleotides reduced the TGF-–induced
increase in Smad7 protein to the control level, whereas
the sense oligonucleotide to Smad7 did not (Fig. 6A).
Next, the apoptotic phenomenon was quantified us-
ing CPP32/caspase-3 fluorometric protease assay. TGF-
treatment alone and TGF- treatment with sense to
Smad7 induced 2.5  0.1- and 2.0  0.1-fold increases in Fig. 6. TGF--induced apoptosis was forestalled by antisense oligonu-
caspase-3 activity, respectively, whereas antisense Smad7 cleotide to Smad7 in CPP32/caspase-3 activity. (A) Western blot analy-
sis of Smad7 on cell lysates from mesangial cells. Rat mesangial cellsoligonucleotides did not elicit significant increases com-
were exposed to TGF- treatment (1 ng/mL), TGF- treatment withpared with controls (Fig. 6B). The effect of the Smad7 antisense oligonucleotide (AS) to Smad7, or TGF- treatment with
antisense oligonucleotides inhibited TGF-–induced apo- sense oligonucleotide to Smad7 (sense) for 24 hours. Twenty micro-
grams of cell lysate protein was used for Western blot analysis. Theptosis in caspase-3 activity to the control level. These re-
protein production of Smad7 was determined by Western blot analysis
sults demonstrated that Smad7 mediated the TGF-– using a specific antibody. (B) Rat mesangial cells were exposed to
TGF- treatment (1 ng/mL), TGF- treatment with AS, or TGF-induced apoptosis in mesangial cells.
treatment with sense for 24 hours. Cell lysate from adherent and floating
cells was used for CPP32/caspase-3 assay (N 
 6; data are mean Smad7 overexpression did not affect NF-B activity in
SEM; *P  0.001).
mesangial cells
Recent reports suggested that TGF- and Smad7 in-
duced apoptosis through different downstream pathways
erase-plasmid, and Smad7 and LacZ were overexpressedin MDCK cells [17] and podocytes [18]. These studies
using the adenoviral method. As TNF- is known tofound that Smad7 inhibited the activity of the survival
elicit significant expression of NF-B [33], rat mesangialNF-B, and proposed that Smad7-mediated apoptosis
cells exposed to TNF-were prepared as positive controlwas induced by the inhibition of NF-B as the cell sur-
for the NF-B activation.vival factor in MDCK cells and podocytes. Thus, we tried
AdCMV-Smad7 inhibited the NF-B–sensitive pro-to determine whether there was a relationship between
moter-luciferase activity to about 76% compared withSmad7 and NF-B in mesangial cells. Rat mesangial cells
were transiently transfected with NF-B-promoter-lucif- the AdCMV-LacZ control infection (Fig. 7A). However,
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Fig. 7. Smad7 did not affect the nuclear fac-
tor-B (NF-B) activity in rat mesangial cells.
(A) NF-B-promoter-luciferase activity. Rat
mesangial cells were transiently co-transfected
with NF-B-promoter-luciferase-plasmid and
-galactosidase plasmid, and then transfected
with adenovirus (AdCMV-Smad7 or AdCMV-
LacZ) or exposed to TNF- (10 ng/mL). Lu-
ciferase-specific activity was determined by
luciferase assay. The luciferase activity was
normalized by -galactosidase activity (N 
 6;
data are mean  SEM; *P  0.001). (B)
EMSA for detection of NF-B DNA-protein
complexes. Rat mesangial cells were trans-
fected with adenovirus (AdCMV-Smad7 or
AdCMV-LacZ) or exposed to TNF- (10
ng/mL). Equal amounts of nuclear extracts (10
g) were analyzed for NF-B–specific DNA-
protein binding using the 32P-labeled consen-
sus NF-B probe. Negative control without
nuclear extracts (lane 1) and positive control
exposed to TNF- (lane 2) and competition
assay with 100-fold excess of unlabeled con-
sensus, or unrelated oligonucleotides (lanes 3
and 4, respectively) were performed to assess
the specificity of the reaction. The cells with-
out any adenoviral transfection, the cells trans-
fected with AdCMV-LacZ, and the cells trans-
fected with AdCMV-Smad7 were performed
(lanes 5, 6, and 7, respectively). NF-B–spe-
cific protein-DNA complex (arrows 1 and 2)
and free radiolabeled probe are indicated. (C )
Western blot analysis on cell lysates from mes-
angial cells. Rat mesangial cells were trans-
fected with either AdCMV-Smad7 or AdCMV-
LacZ for 48 hours. Twenty micrograms of
cell lysate protein was used for Western blot
analysis. The protein production of Ser473-
phospho-specific Akt, total-Akt, Ser32-phos-
pho-specific IB-, and total IB-was deter-
mined by Western blot analysis using specific
antibodies.
the inhibition was not significant. In addition, the NF-B and phospho-IB-, that is, the active forms of Akt and
promoter-luciferase activities of cells transfected with IB-. Figure 7C demonstrates that the protein levels
AdCMV-Smad7 and AdCMV-LacZ were very low com- of Akt phosphorylation observed in the cells transfected
pared with the cells exposed to TNF-. with AdCMV-Smad7 and AdCMV-LacZ were similar.
We next examined the level of NF-B in mesangial Likewise, Smad7 had no noticeable effect on IB-
cell nuclear extracts by EMSA (Fig. 7B). After stimula- activity.
tion by 10 ng/mL TNF-, extracts from positive control These results suggested that Smad7 does not target
transfectants revealed DNA-protein complexes when in- NF-B as a means of potentiating apoptosis in mesan-
cubated with the labeled consensus NK-B probe. How- gial cells.
ever, the NF-B activation in the extracts from control
cells and the cells transfected with AdCMV-Smad7 and
DISCUSSIONAdCMV-LacZ was low and unchanged.
The present experiments using primary rat mesangialTo examine the effect of Smad7 on Akt and IB-
cells demonstrated, firstly, that Smad7 overexpressionactivities, cell lysates from mesangial cells transfected
induced apoptosis, and secondly, that TGF-–inducedwith AdCMV-Smad7 or AdCMV-LacZ were immuno-
blotted with antibodies directed against phospho-Akt apoptosis was mediated by Smad7, but not by Smad2 or
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Smad3. In addition, we showed that Smad7 overexpres- cific discrepancy in the pathways of apoptosis and the
pro-apoptotic effects of TGF- and Smad7.sion increased the caspase-3 activity in the rat mesan-
gial cells. A previous report using podocytes suggested that
TGF- induced apoptosis via an activation of the classicTGF- has been reported to play a role in experimen-
tal glomerulonephritis and human glomerular diseases effector caspase-3, while Smad7 induced apoptosis via
an inhibition of NF-B, independently of the caspase[10, 34, 35]. TGF- expression was reported to be involved
in the pathophysiology of mesangial cells in experimen- cascade [18]. Many different pathways of TGF-– and
Smad7-induced apoptosis in different cell types havetal nephritis [36]. Our current study demonstrates that
TGF- promoted apoptosis through caspase-3 activation been reported [12, 17, 18]. While there are no clear
explanations for these different pathways, differences inin mesangial cells, and that Smad7 mediated TGF-–
induced apoptosis in the same cell type. Patel et al re- cell types may be involved. Mesangial cells and podo-
cytes both constitute the glomerulus, however, theircently demonstrated that TGF- promoted mesangial
cell apoptosis partly through nitric oxide (NO) and a p53- characteristics are very distinct from one another. Mes-
angial cells have the potential to proliferate, while nor-dependent pathway, but they allowed that there could be
a separate p53-independent pathway in TGF-–induced mal podocytes are terminally differentiated quiescent
apoptosis in mesangial cells [12]. Several pathways, in- cells that may require the presence of p27 and p57
cluding NO, p53, caspase cascade, and Smad7, may medi- [43, 44]. Mesangial cells and podocytes in human kidney
ate TGF-–induced mesangial cell apoptosis. exhibit markedly different expression patterns of the cell
Smad7 was originally recognized as the auto-inhibitory cycle proteins [45]. Further, podocytes and mesangial
downstream effector of TGF-. While Smad7 has recently cells differ in their cell injury response to diabetes and
been reported to have an apoptotic effect on some cell hyperlipidemia [46, 47]. In studies using TGF-–trans-
lines [16–18], little is known about the apoptotic phenom- genic mice [18], the two cell types exhibited different
ena of TGF- and Smad7 signaling in mesangial cells. patterns of Smad7 expression and apoptosis over time.
A recent report by Schiffer et al revealed that podocytes To understand further the pathophysiology of glomer-
underwent apoptosis in the early stages of progressive ulonephritis, future studies should be initiated to resolve
glomerulosclerosis in TGF- transgenic mice [18]. Schif- TGF-– and Smad7-signaling networks and the func-
fer’s group showed that this apoptosis was induced by tions of Smad7 in mesangial cells.
TGF- and Smad7, but they did not closely investigate
the relationship between Smad7-induced apoptosis and ACKNOWLEDGMENTS
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